サノフィに関するコメント

📌Last week’s PDUFAs:
$ヘロン・セラピューティクス(HRTX.US)$ : Approved 1/23 🎉
⇒ ZYNRELEF
⇒ Postoperative pain
⇒ sNDA
⇒ PDUFA: 01/23/24
$リキディア・テクノロジーズ(LQDA.US)$ : NDA review ongoing 🤔
⇒ YUTREPIA
⇒ PH-ILD
⇒ NDA
⇒ PDUFA: 01/24/24
$ティラテクノロジーズ(THTX.US)$ : CRL 1/24 🙁
⇒ F8 Formulation of Tesamorelin
⇒ Excess abdominal fat in adults w/ HIV
⇒ sBLA
⇒ PDUFA: 01/22/24
$サノフィ(SNY.US)$ & $リジェネロン・ファーマシューティカルズ(REGN.US)$ : Approved 1/25 🎉
⇒ Dupixent
⇒ Eosinophilic esophagitis (pedia)
⇒ sB...

$サノフィ(SNY.US)$ out of all the TO targets you choose this one? I would have held out a little longer this isn't the lung one you want. when the dust settles you'll see. I still would have tendered 8-9 B for the other one and see if they bite before. if not it's going for dbl digits. ok m shocked you were my favorite even less then 50%. stupid dark horse is in play.

$サノフィ(SNY.US)$  what a dumb move.

📌This week’s PDUFAs:
$ヘロン・セラピューティクス(HRTX.US)$ : 🤔
⇒ ZYNRELEF
⇒ Postoperative pain
⇒ sNDA
⇒ PDUFA: 01/23/24
$リキディア・テクノロジーズ(LQDA.US)$ : 🤔
⇒ YUTREPIA
⇒ PH-ILD
⇒ NDA
⇒ PDUFA: 01/24/24
📌Next week’s PDUFAs:
$サノフィ(SNY.US)$ & $リジェネロン・ファーマシューティカルズ(REGN.US)$ : 🤔
⇒ Dupixent
⇒ Eosinophilic Esophagitis (pedia)
⇒ sBLA
⇒ PDUFA: 01/31/24

Upcoming PDUFA events in Jan '24 🎯
$メルク(MRK.US)$ : 🤔
⇒ KEYTRUDA + EBRT + brachytherapy
⇒ Cervical cancer
⇒ sBLA
⇒ PDUFA: 01/20/24
$ヘロン・セラピューティクス(HRTX.US)$ : 🤔
⇒ ZYNRELEF
⇒ Postoperative pain
⇒ sNDA
⇒ PDUFA: 01/23/24
$リキディア・テクノロジーズ(LQDA.US)$ : 🤔
⇒ YUTREPIA
⇒ PH-ILD
⇒ NDA
⇒ PDUFA: 01/24/24
$サノフィ(SNY.US)$ & $リジェネロン・ファーマシューティカルズ(REGN.US)$ : 🤔
⇒ Dupixent
⇒ Eosinophilic Esophagitis (pedia)
⇒ sBLA
⇒ PDUFA: 01/31/24

no news, guys I also reenter after some gains. $フォートレス・バイオテック(FBIO.US)$ . but this one actually has a lot of project, sadly it lack of cash and equity. it seems so they issue warrant monthly. DER still high. potential BEP, but a bit worried if per month issued warrant. it has position as stock holder in $ムスタング・バイオ(MBIO.US)$, $ジャーニー・メディカル(DERM.US)$ , $チェックポイント･セラピューティックス(CKPT.US)$ .
Hope miracle happens suddenly shows up an acquisition news like $Gracell Biotechnologies(GRCL.US)$ by ...

The FDA PDUFA Calendar is a chronological calendar of PDUFA target dates as well as Advisory meetings (ADCOMM). PDUFA target dates are dates by which the FDA aims to deliver their decision regarding an NDA or BLA filing. These decisions can however come before the PDUFA target date.
$メルク(MRK.US)$$ヘロン・セラピューティクス(HRTX.US)$$リキディア・テクノロジーズ(LQDA.US)$$リジェネロン・ファーマシューティカルズ(REGN.US)$$サノフィ(SNY.US)$

$メイラGTxホールディングス(MGTX.US)$ most stocks latter got acquired at some point by Sanofi $サノフィ(SNY.US)$ in companies where they had invested money in the pipeline or the company.
Will slowly accumulate dips in this name
Last big buyout was $PRVB for my portfolio where Sanofi had invested dollars before FDA decision